Significance
Amino acids are the building blocks of life and important signaling molecules. Despite their common structure, no universal mechanism for amino acid recognition by cellular receptors is currently known. We discovered a simple motif, which binds amino acids in various receptor proteins from all major life-forms. In humans, this motif is found in subunits of calcium channels that are implicated in pain and neurodevelopmental disorders. Our findings suggest that γ-aminobutyric acid–derived drugs bind to the same motif in human proteins that binds natural ligands in bacterial receptors, thus enabling future improvement of important drugs.
Keywords: signal transduction, evolution, serine/threonine kinases, ion channels, gabapentin
Abstract
Amino acids are the building blocks of life, and they are also recognized as signals by various receptors in bacteria, archaea, and eukaryotes. Despite their common basic structure, no universal mechanism for amino acid recognition is currently known. Here, we show that a subclass of dCache_1 (double domain found in calcium channels and chemotaxis receptors, family 1), a ubiquitous extracellular sensory domain, contains a simple motif, which recognizes the amino and carboxyl groups of amino acid ligands. We found this motif throughout the Tree of Life. In bacteria and archaea, this motif exclusively binds amino acids, including γ-aminobutyric acid (GABA), and it is present in all major receptor types. In humans, this motif is found in α2δ-subunits of voltage-gated calcium channels that are implicated in neuropathic pain and neurodevelopmental disorders and in a recently characterized CACHD1 protein. Our findings suggest that GABA-derived drugs bind to the same motif in human α2δ-subunits that binds natural GABA ligands in bacterial chemoreceptors. The exact location on the target protein and the mechanism of binding may enable future improvements of drugs targeting pain and neurobiological disorders.
Amino acids are involved in a variety of cellular processes, including signal transduction. They serve as signals for various pathways in both prokaryotes and eukaryotes (1). Extracellular amino acids and their derivatives are recognized by dedicated receptors, such as G protein–coupled receptors (GPCRs) and ligand-gated ion channels in eukaryotes (2, 3) and chemoreceptors in bacteria and archaea (4, 5). In eukaryotes, Class C GPCRs, including γ-aminobutyric acid (GABA) and metabotropic glutamate receptors, bind amino acid ligands at their Venus flytrap domain (6), whereas in ligand-gated ion channels, such as glycine and GABA receptors, amino acid ligands bind to an unrelated β-sandwich–like domain (7). In bacterial chemoreceptors, amino acids are also recognized by unrelated ligand binding domains [e.g., four-helix bundle (8), double all-helical ligand-binding domain (9), and dCache_1 (double domain found in Calcium channels and chemotaxis receptors, family 1) (10)]. No common mechanism of amino acid sensing that would be present in all domains of life is currently known. Here, we identify a simple conserved motif in the dCache_1 domain, which provides a common molecular mechanism for amino acid sensing for different types of receptors across the Tree of Life. The dCache_1 domain is the largest family of the Cache superfamily—ubiquitous extracellular ligand binding sensors in bacteria and archaea that are also found in eukaryotes (11, 12). dCache_1 domains serve as sensory modules in all major types of bacterial and archaeal signal transduction systems (e.g., chemoreceptors, histidine kinases, diguanylate cyclases and phosphodiesterases, serine/threonine kinases and phosphatases), and they are also present in eukaryotic voltage-gated calcium channel (VGCC) α2δ-subunits. In bacteria, dCache_1 domains bind various ligands, including amino acids, sugars, organic acids, and nucleotides (5, 13). Ligands bind to membrane-distal (10, 14, 15) or membrane-proximal (16, 17) modules of the dCache_1 domain, and induced conformational changes travel via the adjacent transmembrane helix (always located C terminally to the dCache_1 domain) to the downstream cytoplasmic signaling domain, resulting in the activation of a kinase (4, 14, 18) or another type of signaling. Archaeal dCache_1 domains likely function similar to those in bacteria, as they are found in the same type of signal transduction proteins; however, their function in eukaryotes remains unknown.
Results and Discussion
Defining the AA_motif in Bacterial dCache_1 Domains.
In a previous study, we showed that amino acid residues that are involved in binding amino acid ligands by dCache_1 domains from PctABC (pseudomonas chemotaxis transducer-like proteins A, B, and C) chemoreceptors in the bacterium Pseudomonas aeruginosa are conserved in many homologous chemoreceptors from gammaproteobacteria (10). By analyzing several sequences of dCache_1 domains from other distantly related bacterial species that are known to bind amino acids, we found that the same positions are conserved in all of them, whereas this conservation is lost in dCache_1 domains that are known to bind ligands other than amino acids (Fig. 1 A and B and SI Appendix, Table S1). Based on this sequence analysis and the location of these residues on available three-dimensional (3D) structures, we propose the consensus amino acid binding motif (AA_motif) in dCache_1 domains (Fig. 1C), which consists of two parts. Y121, R126, and W128 (from here and throughout the text, all motif positions are numbered according to P. aeruginosa chemoreceptor PctA, accession no. NP_252999.1) that make key contacts with the carboxyl group of the ligand comprise the N-terminal part of the motif, whereas Y144 and D173 that make key contacts with the amino group of the ligand comprise its C-terminal part (Fig. 1D), as demonstrated for chemoreceptors from P. aeruginosa (10), Campylobacter jejuni (14), and Vibrio cholerae (15). R126, W128, and Y129 were also proposed as conserved determinants of amino acid binding by others (14). The motif integrity is dictated by the structural arrangement of its residues in the folded ligand binding pocket, and in prokaryotes, the distance between the N-terminal and C-terminal parts in a primary sequence is fairly short—13 to 17 amino acid residues (Fig. 1B). To further verify the role of the AA_motif in amino acid binding, we mutated the key residues in the dCache_1 domain of the P. aeruginosa chemoreceptor PctA. The R126A substitution led to a 61-fold decrease in the ligand binding affinity by PctA, whereas the D173A substitution completely abolished ligand binding (Fig. 1E and SI Appendix, Fig. S1). Similarly, mutations in these positions in the Tlp3 chemoreceptor in C. jejuni and in the Mlp37 chemoreceptor in V. cholerae significantly diminished amino acid binding (14, 15). Mutations in other positions of this motif also had a strong negative effect on amino acid binding in other bacterial receptors (SI Appendix, Table S1). Consequently, we renamed the AA_motif-containing dCache_1 domains as dCache_1AA.
Identification and Validation of dCache_1AA Domains in Diverse Signaling Proteins from Bacteria and Archaea.
The list of dCache_1AA domains known to bind amino acids (Fig. 1B and SI Appendix, Table S1) was very short; it contains no archaea or eukaryotes and has representatives of only three bacterial phyla of more than a hundred phyla defined by the latest bacterial taxonomy (19). Consequently, we searched for the presence of dCache_1AA domains throughout the Tree of Life. First, using the dCache_1 domain profile Hidden Markov Model (HMM; Protein Families Database [Pfam] accession no. PF02743), we scanned proteomes of 31,910 representative bacterial and archaeal genomes from the Genome Taxonomy Database (19) with the HMMER tool (20). This highly specific HMM detected dCache_1 domains in 86,346 protein sequences. Next, we built a multiple sequence alignment (MSA) of these sequences, tracked MSA positions corresponding to the generalized AA_motif definition, and selected sequences that had the preserved AA_motif. The detailed procedure for the identification of dCache_1AA containing proteins is available in SI Appendix, SI Materials and Methods. The final dataset contained 10,700 bacterial and 108 archaeal sequences with the dCache_1_AA domain (Dataset S1). Taxonomic analysis showed that dCache_1_AA-containing proteins come from representatives of most bacterial and archaeal phyla for which at least 10 high-quality genomes (>90% completeness) were available, indicating their broad phyletic distribution (Dataset S1). Certain variability within the AA_motif permitting amino acid binding was observed (Dataset S1). In addition, we found that ∼6% of motif-containing sequences have a D173N substitution. To verify whether such substitution leads to the lack of amino acid binding, we introduced it in P. aeruginosa PctA and showed that this change leads to a loss of function (Fig. 1E). To summarize, in this part of the study, we identified dCache_1AA domains in thousands of proteins from the majority of bacterial and archaeal phyla, including important human pathogens, such as Yersinia pestis, V. cholerae, Clostridium botulinum, Legionella pneumophila, and Treponema pallidum. These domains were found not only in chemoreceptors but also, in all other major receptor proteins, such as sensor histidine kinases, diguanylate cyclases and phosphodiesterases, serine/threonine kinases, and phosphohydrolases (Dataset S2).
We then performed two types of validation analyses. First, we modeled structures of dCache_1AA domains from several previously unstudied proteins from our final dataset, representing diverse bacterial and archaeal phyla. All models revealed the presence of a typical dCache_1 fold and the characteristic spatial arrangement of the AA_motif residues (SI Appendix, Fig. S2). Second, we performed biochemical assays to demonstrate that dCache_1 domains implicated as amino acid sensors by our computational analyses indeed bind amino acids. To date, all but one known amino acid sensing dCache_1 domain were found in bacterial chemoreceptors that come from representatives of only three bacterial phyla (Fig. 1B and SI Appendix, Table S1). Therefore, we selected targets for experimental validation based on the following characteristics: 1) taxonomy, 2) the type of receptor, and 3) the species pathogenicity status (Fig. 2 and SI Appendix, Table S2). Ligand binding to recombinant dCache_1 domains was analyzed using differential scanning fluorimetry–based thermal shift assays followed by isothermal titration calorimetry, as previously described (21, 22) (SI Appendix, SI Materials and Methods). Satisfactorily, all ligands that bound to selected targets were amino acids (Fig. 2 and SI Appendix, Figs. S3–S10 and Table S2). The ligand binding affinity of the archaeal protein was low, whereas all bacterial proteins recognized their ligands with high affinity (KD values in the nanomolar or lower micromolar concentration range) (Fig. 2) that are typical of functionally characterized bacterial sensor proteins (23). These experiments validated our computational predictions and confirmed that 1) dCache_1AA domains are amino acid sensors and that 2) they are present in major classes of bacterial and archaeal signal transduction proteins, including those from common pathogens. Furthermore, small molecule ligands for bacterial serine/threonine kinases (Fig. 2) were identified.
Search for the AA_motif in Eukaryotes.
In eukaryotes, Cache domains were initially identified only in metazoan VGCC α2δ-subunits (11), where they were described as “unusual” and “circular permutations.” Later, these were reclassified as dCache_1 domains with “uncertain boundaries” and detected in some other eukaryotic signal transduction proteins (12); however, no ligands were known to bind to these domains. In humans, α2δ-subunits are widely expressed in both the central and peripheral nervous systems and are implicated in various disorders, including schizophrenia, bipolar disorder, autism spectrum disorders, epilepsies, and neuropathic pain (24, 25). The α2δ-1– and α2δ-2–subunits bind GABA-derived drugs gabapentin, pregabalin, and mirogabalin, which are of therapeutic benefit in neuropathic pain conditions (26). Coincidentally, GABA is a natural ligand for dCache_1AA domains of several bacterial chemoreceptors (SI Appendix, Table S1); however, it is unknown whether GABA-derived drugs bind to the dCache_1 domain, and the precise location of this domain in α2δ is also unknown. In order to find out whether eukaryotic dCache_1 domains might contain the AA_motif, we searched for eukaryotic dCache_1 proteins in several databases (SI Appendix, SI Materials and Methods) and tracked the AA_motif positions in corresponding domains, building MSAs. The analysis identified several hundred eukaryotic sequences with the AA_motif (Dataset S3), including α2δ-subunits and the recently characterized CACHD1 proteins that also modulate VGCCs and are highly expressed in the thalamus, hippocampus, and cerebellum (27, 28). We also found numerous previously unidentified dCache_1 proteins in protozoan lineages (Dataset S3). In CACHD1, the AA_motif was mapped to a C-terminal region, where our analysis revealed a eukaryotic version of the dCache_1 domain (Fig. 3 and SI Appendix, Fig. S11). No such motif was detected in the dCache_1 domain corresponding to VGCC_α2 in α2δ-subunits (Fig. 3). Surprisingly, we found the N-terminal part of the AA_motif, YxxxxRxWY, in the domain currently annotated as VWA_N (a domain located N terminally to the VWA [von Willebrand factor type A] domain; Pfam accession no. PF08399). Subsequent alignment of α2δ and CACHD1 with bacterial dCache_1_AA showed that bacterial sequences are well aligned with two regions of α2δ and CACHD1 proteins that are separated by the VWA domain (SI Appendix, Fig. S11). In the region located downstream of the VWA domain in the α2δ-sequence, we identified the C-terminal part of the AA_motif, Y[x∼27 to 34]D (Fig. 3 and SI Appendix, Fig. S11).
AA_motif in Eukaryotes Is Split in Sequence but Preserved in 3D Structure.
We took advantage of the recently published cryogenic electron microscopy (cryo-EM) structure of the rabbit VGCC and its α2δ-1–subunit (29) to scrutinize the α2δ-structure in light of our findings. A careful assessment of the α2δ-1–subunit structure showed the presence of two dCache_1 domains and one VWA domain (Fig. 3). Both dCache_1 domains have a long stalk α-helix, α1, followed by the upper distal and lower proximal modules. Usually in bacteria, the dCache_1 domain is flanked by two transmembrane regions, one preceding the stalk α1-helix and another following the membrane-proximal module (10). However, the topology tracking of rabbit α2δ-1 and MSA analysis showed that the stalk α1-helix of the C-terminal dCache_1 (termed here as second dCache_1) is not followed by distal and proximal modules but instead, by a stalk α1-helix of the N-terminal dCache_1 (termed here as first dCache_1) and then, by its partial distal module (Fig. 3E). The next structural element is the VWA domain, which is followed by the remaining part of the first dCache_1 distal module and the proximal module, and then, the sequence proceeds to distal and proximal modules of the second dCache_1. This analysis indicates that the first dCache_1 is inserted into the loop between α1-helix and the distal module of the second dCache_1. Furthermore, it confirmed that the VWA domain is inserted into the first dCache_1 domain between α4 and β4 and splits the AA_motif. As a result, in a primary sequence, the distance between its N-terminal and C-terminal parts becomes much longer than that in prokaryotes. Remarkably, although the AA_motif in the first dCache_1 is split by the VWA domain insertion, the fold of the distal module is intact, and amino acid residues that constitute the AA_motif N-terminal and C-terminal parts come together in 3D and form the interface matching the one in the PctA chemoreceptor (Fig. 3D and SI Appendix, Figs. S12 and S13). Excised and concatenated dCache_1 domains of α2δ and CACHD1 proteins perfectly align with bacterial dCache_1 domains and find them in Basic Local Alignment Search Tool searches (Dataset S4). Next, we performed pairwise structural comparison of the dCache_1 domain from the P. aeruginosa PAO1 chemoreceptor PctA with both dCache_1 domains of the rabbit α2δ-1–subunit. Remarkably, the PctA dCache_1 domain aligned very well with both dCache_1 domains of the α2δ-1–subunit. The alignment shows essentially identical topologies of the distal and proximal modules; however, additional secondary structure elements are present in α2δ-1, especially in the second dCache_1 (SI Appendix, Fig. S12).
α2δ-1–Subunit Binds Amino Acid Ligands through the AA_motif.
R241A substitutions in the murine and porcine α2δ-1 (corresponding to R126 in the PctA N-terminal part of the AA_motif) were shown to completely abolish the ability to bind pregabalin and gabapentin, respectively (30, 31). Furthermore, the R241A substitution in the murine α2δ-1 has been shown to result in a significant decrease in divalent cation current through CaV2.2 (N-type voltage gated calcium) channels by an effect on channel trafficking (31). Leucine and isoleucine were shown to bind to α2δ-1 (32) and inhibit gabapentin binding by the subunit (33). To further explore whether the AA_motif in α2δ-1 might serve as a site for binding GABA-derived drugs and amino acids, we performed computational docking experiments with the available structure of the rabbit α2δ-1–protein and 20 α-amino acids, GABA, and drug molecules gabapentin, pregabalin, and mirogabalin. Using the docking results, we calculated polar contacts made between these ligands and α2δ-1. We found that all these molecules made contacts with the AA_motif residues (Dataset S5) (the Protein Data Bank [PDB] file is available at https://github.com/ToshkaDev/Motif) (34). Most ligands made contacts with the Y and W residues of the N-terminal motif part and with the Y and D residues of its C-terminal part (Dataset S5 and SI Appendix, Fig. S13). The relative affinities agree with the available data. For example, the docking experiments demonstrated that leucine has higher affinity to α2δ-1 than isoleucine (Dataset S5), which is consistent with published experimental data (32, 33). The order of affinities mirogabalin > gabapentin > pregabalin also agrees with recent experimental data (35).
To investigate the effect of mutation of another key position (Asp) in the C-terminal part of the AA_motif in the mammalian α2δ-1–protein, we replaced Asp491 (corresponding to D173 in PctA) by Ala in rat α2δ-1 and measured its expression at the plasma membrane of tsA-201 cells in the presence of gabapentin. We found that, whereas gabapentin inhibited the wild-type α2δ-1 trafficking in tsA-201 cells manifested by reduced expression at the plasma membrane by 43.2 ± 1.8% (100 μM gabapentin) and 55.6 ± 8.4% (1 mM gabapentin), D491A mutation abolished this effect of gabapentin (10.2 ± 12.0% inhibition by 1 mM gabapentin) (Fig. 4). Thus, this residue plays a critical role in ligand binding by the eukaryotic α2δ-1–protein. We previously found (36) and confirmed here a similar result for the R241A mutation in the N-terminal part of the AA_motif (4.2 ± 7.1% inhibition by 1 mM gabapentin).
Human and Bacterial Proteins Bind Ligands in a Similar Fashion.
We structurally superimposed the ligand binding module of the first dCache_1 domain of the rabbit α2δ-1–subunit with that of the PctA dCache_1 domain (SI Appendix, Fig. S13A). The ligand binding pockets were similar in shape and size, which is astonishing considering the evolutionary time lapsed from bacteria to mammals and the presence of the VWA insertion. Furthermore, the AA_motif residues in the two structures are located at nearly the same positions. Next, we closely examined the rabbit α2δ-1–subunit ligand binding pocket with docked L-Ile in comparison with that of the PctA dCache_1 domain in complex with L-Ile (PDB ID code 5T65) (Fig. 5 and SI Appendix, Table S3). We observed that ligands made polar contacts with the AA_motif in these two molecules in a similar fashion. The amino group of L-Ile forms hydrogen bonds with the third Y and last D of the AA_motif, whereas the carboxyl group is bound by R and W in both first dCache_1 domain of α2δ-1 and dCache_1 domain of PctA (Fig. 5). The docking experiments also indicated that L-Leu, gabapentin, pregabalin, and mirogabalin are bound through the AA_motif of the α2δ-1–subunit following the same pattern (Fig. 5 and SI Appendix, Fig. S13 B–D). The first Y and W of the AA_motif coordinate the ligand carboxyl groups, and the third Y (except for the L-Leu ligand) and D interact with amino groups of the ligands. The carboxyl group of pregabalin is additionally stabilized by a hydrogen bond with R of the AA_motif.
To demonstrate that the motif is capable of binding amino acids and their derivatives in invertebrates, we have run docking experiments using the α2δ-protein structure from Drosophila melanogaster modeled by AlphaFold (37), amino acid ligands, and their derivatives. The above-described ligand binding pattern was again observed (Dataset S5 and SI Appendix, Fig. S14) (the PDB file is available at https://github.com/ToshkaDev/Motif) (34).
CACHD1 and α2δ-1 Have Similar Domain Architectures, but Their AA_motifs Are Arranged Differently.
We have obtained a structural model of human CACHD1 protein from the AlphaFold Protein Structure Database (https://alphafold.ebi.ac.uk/). Structural alignment of the CACHD1 model with the rabbit α2δ-1 cryo-EM structure demonstrated that CACHD1 has the same structural composition as the α2δ-1–subunit, with a few differences (Fig. 3 and SI Appendix, Fig. S15). Similar to the α2δ-1–subunit, CACHD1 consists of two dCache_1 domains, one inserted into the other one and the VWA domain inserted into the first dCache_1 domain. The presence of these structural parts was also confirmed by the MSA (SI Appendix, Fig. S11). However, α2δ-proteins possess a distinctive long insertion inside the second dCache_1 between α9-helix and β9-sheet, whereas it is significantly shorter in CACHD1 protein (SI Appendix, Fig. S11). Another essential difference between α2δ and CACHD1 is the AA_motif placement. Unlike α2δ-proteins that all carry the AA_motif in the first dCache_1, CACHD1 protein has an intact AA_motif in the distal module of the second dCache_1 (Fig. 3 and SI Appendix, Fig. S11). In order to obtain insights into ligand binding capabilities of CACHD1, we docked amino acids and GABA-derived drug molecules to the distal module of the second dCache_1 domain of the modeled human CACHD1 structure. The ligands made hydrogen bonds with the AA_motif residues following the mentioned pattern (Dataset S5 and SI Appendix, Fig. S14) (the PDB file is available at https://github.com/ToshkaDev/Motif); R and W of the N-terminal part of the AA_motif coordinate the ligand carboxyl group, whereas Y and D of the C-terminal part of the motif interact with the amino group of the ligands. Essentially, the same ligand binding pattern was observed with the D. melanogaster CACHD1 protein structure modeled by AlphaFold (Dataset S5 and SI Appendix, Fig. S14) (the PDB file is available at https://github.com/ToshkaDev/Motif) (34).
Evolution of the Amino Acid Binding dCache_1 Domain in Eukaryotes.
To establish the prevalence of the AA_motif in Eukaryota and its evolutionary history, we analyzed available eukaryotic genomes from several databases (SI Appendix, SI Materials and Methods). We found that dCache_1AA-containing proteins are present in almost all major eukaryotic groups (National Center for Biotechnology Information taxonomy): Euglenozoa, Heterolobosea, SAR (stramenopiles, alveolates, and Rhizaria supergroup), Haptista, Choanoflagellida, Archaeplastida, and Metazoa (Fig. 6 and Dataset S3). We could not detect dCache_1AA proteins in any genomes of angiosperms (flowering plants), fungi, and two protozoan lineages, where they were presumably lost. Domains of the Cache superfamily (Pfam CL0165), to which the dCache_1 belongs, have been shown to have bacterial origins, and their presence in archaea and eukaryotes was attributed to horizontal gene transfer (12). We found that in all eukaryotic proteins that contain dCache_1 domains, the VWA domain is inserted in one of them, which suggests that this insertion probably occurred in the last eukaryotic common ancestor (LECA). We have found that proteins containing two dCache_1 domains, where one (with the VWA insertion) is inserted into another, are present in all branches of eukaryotes. In addition, we identified proteins that contained only one dCache_1 (with the VWA domain insertion). All of these proteins were found in diverse eukaryotes, excluding vertebrates (Fig. 6 and SI Appendix, Fig. S16). Thus, two events happened around LECA: 1) insertion of the VWA domain into a dCache_1 domain and 2) insertion of this dCache_1-VWA module into another dCache_1 domain. Many protists and invertebrates have two types of dCache_1AA domain containing proteins: one with a single dCache_1 domain with the VWA insertion and one with two dCache_1 domains, one of which has the VWA insertion (SI Appendix, Fig. S16). Remarkably, in some members of the Streptophyta clade, the dCache_1AA domain with the VWA insertion is present in a serine/threonine kinase, resembling some of the bacterial dCache_1-containing proteins (Fig. 6).
To further understand evolutionary relationships between the proteins containing two dCache_1 domains, we inferred two phylogenetic trees using maximum likelihood estimation and Bayesian inference, respectively. The trees showed high agreement with each other (available at https://github.com/ToshkaDev/Motif) (34). We used the Bayesian tree for the subsequent analysis (SI Appendix, Fig. S17), which revealed two clusters: α2δ and CACHD1. The α2δ-cluster contains only metazoan sequences, including four α2δ-proteins from the human genome. In vertebrates, α2δ-1– and α2δ-2–sequences form one group, while α2δ-3 and α2δ-4 form another group. This suggests that a primordial α2δ-ancestor in vertebrates duplicated, giving rise to α2δ-1/α2δ-2– and α2δ-3/α2δ-4–ancestors, and subsequent duplications led to four current paralogs. α2δ-proteins in bony fishes have undergone additional duplications (SI Appendix, Figs. S16 and S17).
The CACHD1 cluster includes one protein encoded in the human genome, CACHD1, and proteins from metazoan organisms (SI Appendix, Fig. S17). Vertebrates have only one copy of CACHD1, while organisms preceding vertebrates have paralogous proteins in varying numbers (SI Appendix, Figs. S16 and S17). At the root of the tree and close to it, there are proteins that have the AA_motif preserved in the distal modules of both dCache_1 domains, which suggests that the ancestral proteins had the AA_motif in both dCache_1 domains (also supported by the phyletic distribution pattern) (SI Appendix, Fig. S16). In the course of evolution, the AA_motif was differentially lost in various groups of organisms (SI Appendix, Fig. S17). Eukaryotes prior to vertebrates have dCache_1AA proteins from all of the described groups: single dCache_1AA proteins, proteins from α2δ and CACHD1 clusters, and “double-AA_motif” proteins with the AA_motif preserved in both domains of double-dCache_1 proteins (SI Appendix, Fig. S16). Phylogenetic reconstruction suggests that duplications of proteins originating from this early double-AA_motif group gave rise to α2δ and CACHD1 clusters (SI Appendix, Figs. S16 and S17). In α2δ-proteins, the AA_motif has been preserved predominantly in the first dCache_1 domain, while in CACHD1 proteins, it is in the second dCache_1 domain. Our analysis also demonstrated that the first dCache_1 domain of α2δ-subunits is under stronger selective pressure than the second dCache_1; in contrast, both dCache_1 domains of the CACHD1 protein are under strong selective pressure (SI Appendix, SI Materials and Methods). Phylogenetic analysis and sequence similarity searches (Dataset S4) did not allow us to definitively conclude which exact bacterial group could give rise to eukaryotic proteins.
Conclusions
In this work, we have described a universal amino acid binding sensor, which is present throughout the Tree of Life. We showed that these sensors bind amino acid ligands through a simple amino acid recognition motif that has been preserved over 3 billion years and used in all major cellular life-forms. We assign specific biological function—amino acid sensing—to thousands of receptors in bacteria, archaea, and eukaryotes. It is especially important for human pathogens because amino acids are key mediators of pathogenicity (38). The vast majority of sensor proteins encoded in genomes of various organisms remain unstudied, and signals that they recognize are unknown. Sequence analysis alone does not permit their identification due to extreme sequence variation and complex evolutionary trajectories of sensory domains. On the other hand, structural studies and biochemical characterization can only be performed for a small fraction of sensor proteins identifiable in genome databases. Here, we show how combining these two strategies results in precise predictions for an important class of biological signals. It is likely that similar approaches can be utilized for functional annotation of other classes of sensor proteins. During the course of this study, we identified the AA_motif in medically important CACHD1 proteins and α2δ-subunits of VGCCs and implicated it as the binding site for GABA-derived drugs in human α2δ-subunits. This finding provides opportunities for improving drugs targeting various neurobiological disorders.
Materials and Methods
Public databases and bioinformatics tools used throughout this study are described in detail in SI Appendix. Detailed procedures for identification of AA_motif-containing proteins in prokaryotes and eukaryotes are also available in SI Appendix. Computational docking was carried out using AutoDock Vina (39). MSAs were built using MAFFT (40). Phylogenetic inference was performed using RaXML (41) and MrBayes (42). Identification and analysis of protein domains were performed using TREND (21).
Protein expression, purification, thermal shift assays, isothermal titration calorimetry, and site-specific mutagenesis of bacterial and archaeal proteins were performed using published protocols (22, 43) and are described in detail in SI Appendix. Imaging cell surface expression of the calcium channel α2δ-1–subunit was carried out as previously described (36), and details are provided in SI Appendix.
Supplementary Material
Acknowledgments
This study was supported by Spanish Ministry of Science and Innovation/Agencia Estatal de Investigación Grants PID2019-103972GA-100 (to M.A.M.) and PID2020-112612GB-100 (to T.K.); Wellcome Trust Grant 206279\Z\17\Z (to A.C.D.); Junta de Andalucia Grant P18-FR-1621 (to T.K.); and NIH Grant 1R35GM131760 (to I.B.Z.). K.M.P. and A.C.D. thank Wendy S. Pratt for molecular biology support.
Footnotes
The authors declare no competing interest.
This article is a PNAS Direct Submission.
This article contains supporting information online at https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2110415119/-/DCSupplemental.
Data Availability
Alignment, tree, model, and anonymized MSA data have been deposited in GitHub (https://github.com/ToshkaDev/Motif). All other data are included in the manuscript and/or supporting information.
References
- 1.Chantranupong L., Wolfson R. L., Sabatini D. M., Nutrient-sensing mechanisms across evolution. Cell 161, 67–83 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ellaithy A., Gonzalez-Maeso J., Logothetis D. A., Levitz J., Structural and biophysical mechanisms of class C G protein-coupled receptor function. Trends Biochem. Sci. 45, 1049–1064 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Laverty D., et al. , Cryo-EM structure of the human α1β3γ2 GABAA receptor in a lipid bilayer. Nature 565, 516–520 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Parkinson J. S., Hazelbauer G. L., Falke J. J., Signaling and sensory adaptation in Escherichia coli chemoreceptors: 2015 update. Trends Microbiol. 23, 257–266 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ortega Á., Zhulin I. B., Krell T., Sensory repertoire of bacterial chemoreceptors. Microbiol. Mol. Biol. Rev. 81, e00033-17 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Koehl A., et al. , Structural insights into the activation of metabotropic glutamate receptors. Nature 566, 79–84 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Du J., Lü W., Wu S., Cheng Y., Gouaux E., Glycine receptor mechanism elucidated by electron cryo-microscopy. Nature 526, 224–229 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Milburn M. V., et al. , Three-dimensional structures of the ligand-binding domain of the bacterial aspartate receptor with and without a ligand. Science 254, 1342–1347 (1991). [DOI] [PubMed] [Google Scholar]
- 9.Elgamoudi B. A., et al. , The Campylobacter jejuni chemoreceptor Tlp10 has a bimodal ligand-binding domain and specificity for multiple classes of chemoeffectors. Sci. Signal. 14, eabc8521 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Gavira J. A., et al. , How bacterial chemoreceptors evolve novel ligand specificities. MBio 11, e03066-19 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Anantharaman V., Aravind L., Cache—a signaling domain common to animal Ca(2+)-channel subunits and a class of prokaryotic chemotaxis receptors. Trends Biochem. Sci. 25, 535–537 (2000). [DOI] [PubMed] [Google Scholar]
- 12.Upadhyay A. A., Fleetwood A. D., Adebali O., Finn R. D., Zhulin I. B., Cache domains that are homologous to, but different from PAS domains comprise the largest superfamily of extracellular sensors in prokaryotes. PLoS Comput. Biol. 12, e1004862 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Matilla M. A., Velando F., Martin-Mora D., Monteagudo-Cascales E., Krell T., A catalogue of signal molecules that interact with sensor kinases, chemoreceptors and transcriptional regulators. FEMS Microbiol. Rev. 46, fuab043 (2022). [DOI] [PubMed] [Google Scholar]
- 14.Liu Y. C., Machuca M. A., Beckham S. A., Gunzburg M. J., Roujeinikova A., Structural basis for amino-acid recognition and transmembrane signalling by tandem Per-Arnt-Sim (tandem PAS) chemoreceptor sensory domains. Acta Crystallogr. D Biol. Crystallogr. 71, 2127–2136 (2015). [DOI] [PubMed] [Google Scholar]
- 15.Nishiyama S., et al. , Identification of a Vibrio cholerae chemoreceptor that senses taurine and amino acids as attractants. Sci. Rep. 6, 20866 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Machuca M. A., et al. , Helicobacter pylori chemoreceptor TlpC mediates chemotaxis to lactate. Sci. Rep. 7, 14089 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Johnson K. S., et al. , The dCache chemoreceptor TlpA of Helicobacter pylori binds multiple attractant and antagonistic ligands via distinct sites. MBio 12, e0181921 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Gushchin I., et al. , Mechanism of transmembrane signaling by sensor histidine kinases. Science 356, eaah6345 (2017). [DOI] [PubMed] [Google Scholar]
- 19.Parks D. H., et al. , A standardized bacterial taxonomy based on genome phylogeny substantially revises the tree of life. Nat. Biotechnol. 36, 996–1004 (2018). [DOI] [PubMed] [Google Scholar]
- 20.Eddy S. R., Accelerated profile HMM searches. PLoS Comput. Biol. 7, e1002195 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Gumerov V. M., Zhulin I. B., TREND: A platform for exploring protein function in prokaryotes based on phylogenetic, domain architecture and gene neighborhood analyses. Nucleic Acids Res. 48, W72–W76 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Rico-Jiménez M., et al. , Paralogous chemoreceptors mediate chemotaxis towards protein amino acids and the non-protein amino acid gamma-aminobutyrate (GABA). Mol. Microbiol. 88, 1230–1243 (2013). [DOI] [PubMed] [Google Scholar]
- 23.Matilla M. A., Martín-Mora D., Krell T., The use of isothermal titration calorimetry to unravel chemotactic signalling mechanisms. Environ. Microbiol. 22, 3005–3019 (2020). [DOI] [PubMed] [Google Scholar]
- 24.Dolphin A. C., Voltage-gated calcium channels and their auxiliary subunits: Physiology and pathophysiology and pharmacology. J. Physiol. 594, 5369–5390 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Dolphin A. C., Calcium channel auxiliary α2δ and β subunits: Trafficking and one step beyond. Nat. Rev. Neurosci. 13, 542–555 (2012). [DOI] [PubMed] [Google Scholar]
- 26.Calandre E. P., Rico-Villademoros F., Slim M., Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: A review of their clinical pharmacology and therapeutic use. Expert Rev. Neurother. 16, 1263–1277 (2016). [DOI] [PubMed] [Google Scholar]
- 27.Cottrell G. S., et al. , CACHD1 is an α2δ-like protein that modulates CaV3 voltage-gated calcium channel activity. J. Neurosci. 38, 9186–9201 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Dahimene S., et al. , The α2δ-like protein Cachd1 increases N-type calcium currents and cell surface expression and competes with α2δ-1. Cell Rep. 25, 1610–1621.e5 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Wu J., et al. , Structure of the voltage-gated calcium channel Ca(v)1.1 at 3.6 Å resolution. Nature 537, 191–196 (2016). [DOI] [PubMed] [Google Scholar]
- 30.Wang M., Offord J., Oxender D. L., Su T. Z., Structural requirement of the calcium-channel subunit alpha2delta for gabapentin binding. Biochem. J. 342, 313–320 (1999). [PMC free article] [PubMed] [Google Scholar]
- 31.Field M. J., et al. , Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc. Natl. Acad. Sci. U.S.A. 103, 17537–17542 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Brown J. P., Dissanayake V. U., Briggs A. R., Milic M. R., Gee N. S., Isolation of the [3H]gabapentin-binding protein/alpha 2 delta Ca2+ channel subunit from porcine brain: Development of a radioligand binding assay for alpha 2 delta subunits using [3H]leucine. Anal. Biochem. 255, 236–243 (1998). [DOI] [PubMed] [Google Scholar]
- 33.Dooley D. J., Donovan C. M., Meder W. P., Whetzel S. Z., Preferential action of gabapentin and pregabalin at P/Q-type voltage-sensitive calcium channels: Inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slices. Synapse 45, 171–190 (2002). [DOI] [PubMed] [Google Scholar]
- 34.V. M. Gumerov et al. , “Motif.” GitHub. https://github.com/ToshkaDev/Motif. Deposited 18 February 2022. [Google Scholar]
- 35.Kim J. Y., Abdi S., Huh B., Kim K. H., Mirogabalin: Could it be the next generation gabapentin or pregabalin? Korean J. Pain 34, 4–18 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Cassidy J. S., Ferron L., Kadurin I., Pratt W. S., Dolphin A. C., Functional exofacially tagged N-type calcium channels elucidate the interaction with auxiliary α2δ-1 subunits. Proc. Natl. Acad. Sci. U.S.A. 111, 8979–8984 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Jumper J., et al. , Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Ren W., et al. , Amino acids as mediators of metabolic cross talk between host and pathogen. Front. Immunol. 9, 319 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Trott O., Olson A. J., AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455–461 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Katoh K., Standley D. M., MAFFT multiple sequence alignment software version 7: Improvements in performance and usability. Mol. Biol. Evol. 30, 772–780 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Stamatakis A., RAxML version 8: A tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30, 1312–1313 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Ronquist F., et al. , MrBayes 3.2: Efficient Bayesian phylogenetic inference and model choice across a large model space. Syst. Biol. 61, 539–542 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Fernández M., et al. , High-throughput screening to identify chemoreceptor ligands. Methods Mol. Biol. 1729, 291–301 (2018). [DOI] [PubMed] [Google Scholar]
- 44.Zhao Y., et al. , Molecular basis for ligand modulation of a mammalian voltage-gated Ca2+ channel. Cell 177, 1495–1506.e12 (2019). [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Alignment, tree, model, and anonymized MSA data have been deposited in GitHub (https://github.com/ToshkaDev/Motif). All other data are included in the manuscript and/or supporting information.